Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT 1 MF-2 smooth muscle cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1397-1401

  Parkinson, Fiona E ^a,b   Geiger, Jonathan D ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Medical Research Council of   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 IODOTUBERCIDIN; ADENOSINE KINASE; MEGLUMINE; NITROBENZYLTHIOINOSINE; NUCLEOSIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SYRIAN HAMSTER; TRANSPORT KINETICS;

ADENOSINE KINASE; ANIMALS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; KINETICS; MUSCLE, SMOOTH; NUCLEOSIDES; RADIOLIGAND ASSAY; TUBERCIDIN;

EID: 0030426817     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. CASS, C. E.: Nucleoside transport. In Drug Transport in Antimicrobial and Anticancer Chemotherapy, ed. by N. H. Georgopapadakou, pp. 403-451. Marcel Dekker, New York, 1995.
2. CASS, C. E., GAUDETTE, L. A. AND PATERSON, A. R. P.: Mediated transport of nucleosidea in human erythrocytes: Specific binding of the inhibitor nitrobenzylthioinosine to nucleoside transport sites in the erythrocyte membrane. Biochim. Biophys. Acta 345: 1-10, 1974.
3. 5O) of an enzymatic reaction. Biochem. Pharmacol. 22: 3099-3108, 1973.
4. CONANT, A. R. AND JARVIS, S. M.: Nucleoside influx and efflux in guinea-pig ventricular myocytes. Inhibition by analogues of lidoflazine. Biochem. Pharmacol. 48: 873-880, 1994.
5. COTTAM, H. B., WASSON, D. B., SHIH, H. C., RAYCHAUDHURI, A., DIPASQUALE, G. AND CARSON, D. A.: New adenosine kinase inhibitors with oral antiinflammatory activity: Synthesis and biological evaluation. J. Med. Chem. 36: 3424-3430, 1993.
6. CRAWFORD, C. R. AND BELT, J. A.: Sodium-dependent, concentrative nucleoside transport in Walker 256 rat carcinosarcoma cells. Biochem. Biophys. Res. Commun. 176: 846-851, 1991.
7. DAVIES, L. P., BAIRD LAMBERT, J. AND MARWOOD, J. F.: Studies on several pyrrolo[2,3-d]pyrimidine analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivo. Biochem. Pharmacol. 35: 3021-3029, 1986.
8. DAVIES, L. P. AND COOK, A. F.: Inhibition of adenosine kinase and adenosine uptake in guinea-pig CNS tissue by halogenated tubercidin analogues. Life Sci. 56: 345-349, 1995.
9. DAVIES, L. P. AND HAMBLEY, J. W.: Diazepam inhibition of adenosine uptake in the CNS: Lack of effect on adenosine kinase. Gen. Pharmacol. 14: 307-309, 1983.
10. DAWICKI, D. D., AGARWAL, K. C. AND PARKS, R. E. J.: Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine. Biochem. Pharmacol. 34: 3965-3972, 1985.
11. DECKING, U. K., ALVES, C., SPAHR, R. AND SCHRADER, J.: 2-Fluoroadenosine uptake by erythrocytes and endothelial cells studied by 19F-NMR. Am. J. Physiol. 266: H1596-H603, 1994.
12. ELY, S. W., MATHERNE, G. P., COLEMAN, S. D. AND BERNE, R. M.: Inhibition of adenosine metabolism increases myocardial interstitial adenosine concentrations and coronary flow. J. Mol. Cell. Cardiol. 24:1321-1332,1992.
13. GEIGER, J. D. AND FYDA, D. M.: Adenosine transport in nervous system tissues. In Adenosine in the Nervous System, ed. by T. Stone, pp. 1-23, Academic Press, Ltd., London, 1991.
14. GERWINS, P., NORDSTEDT, C. AND FREDHOLM, B. B.: Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells. Mol. Pharmacol. 38: 660-666, 1990.
15. 3H]adenosine in rat cerebral cortical synaptoneurosomes. J. Neurochem. 58:1699-1705, 1992.
16. HARLEY, E. R., PATERSON, A. R. P. AND CASS, C. E.: Initial rate kinetics of the transport of adenosine and 4-amino-7-(b-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine (tubercidin) in cultured cells. Cancer Res. 42:1289-1295, 1982.
17. HENDERSON, J. F., PATEBSON, A. R. P., CALDWELL, I. C., PAUL, B., CHAN, M. C. AND LAU, K. F.: Inhibitors of nucleoside and nucleotide metabolism. Cancer Chemother. Rep. 3: 71-85, 1972.
18. JONES, K. W., RYLETT, R. J. AND HAMMOND, J. R.: Effect of cellular differentiation on nucleoside transport in human neuroblastoma cells. Brain Res. 660: 104-112, 1994.
19. KROLL, K., DECKING, U. K., DREIKORN, K. AND SCHRADER, J.: Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart. Circ. Res. 73: 846-856, 1993.
20. Lin, B. B., HURLEY, M. C. AND Fox, I. H.: Regulation of adenosine kinase by adenosine analogs. Mol. Pharmacol. 34: 501-505, 1988.
21. LLOYD, H. G. E. AND FREDHOLM, B. B.: Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem. Int. 26: 387-395, 1995.
22. NEWBY, A. C.: The interaction of inhibitors with adenosine metabolising enzymes in intact isolated cells. Biochem. Pharmacol. 30: 2611-2615, 1995.
23. NORRIS, J. S., GORSKI, J. AND KOHLER, P. O.: Androgen receptors in a Syrian hamster ductus deferens tumour cell. Nature (Lond.) 248:422-424, 1974.
24. PAK, M. A., HAAS, H. L., DECKING, U. K. M. AND SCHRADER, J.: Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacology 33:1049-1053, 1994.
25. 1 MF-2 smooth muscle cells: Inhibition by metabolites of propentofylline. Eur. J. Pharmacol., in press, 1996.
26. PLAGEMANN, P. G. AND ARAN, J. M.: Na(+)-dependent, active nucleoside transport in mouse spleen lymphocytes, leukemia cells, fibroblasts and macrophages, but not in equivalent human or pig cells; dipyridamole enhances nucleoside salvage by cells with both active and facilitated transport. Biochim. Biophya. Acta 1025: 32-42, 1990.
27. SCIOTTI, V. M. AND VAN WYLEN, D. G.: Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase. J. Cerebr. Blood Flow Metab. 13: 201-207, 1993.
28. Wu, P. H., BARRACO, R. A. AND PHILLIS, J. W.: Further studies on the inhibition of adenosine uptake into rat brain synaptosomes by adenosine derivatives and methylxanthines. Gen. Pharmacol. 15: 251-254, 1984.
29. ZHANG, G., FRANKLIN, P. H. AND MURRAY, T. F.: Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J. Pharmacol. Exp. Ther. 264: 1415-1424, 1993.